Found: 46
Select item for more details and to access through your institution.
Reduction of Intimal Hyperplasia withRe-188-labeled Stents in a Rabbit Model at 7and 26 Weeks: An Experimental Study.
- Published in:
- CardioVascular & Interventional Radiology, 2005, v. 28, n. 5, p. 632, doi. 10.1007/s00270-004-0308-x
- By:
- Publication type:
- Article
<sup>18</sup>F-Radiolabeling of Aromatic Compounds Using Triarylsulfonium Salts.
- Published in:
- European Journal of Organic Chemistry, 2012, v. 2012, n. 5, p. 889, doi. 10.1002/ejoc.201101730
- By:
- Publication type:
- Article
Silicon-Based Building Blocks for One-Step.
- Published in:
- Angewandte Chemie International Edition, 2008, v. 47, n. 26, p. 4922, doi. 10.1002/anie.200705854
- By:
- Publication type:
- Article
<sup>18</sup>F-Labeled Bombesin Analog for Specific and Effective Targeting of Prostate Tumors Expressing Gastrin-Releasing Peptide Receptors.
- Published in:
- Journal of Nuclear Medicine, 2011, v. 52, n. 2, p. 270, doi. 10.2967/jnumed.110.081620
- By:
- Publication type:
- Article
Targeting of HER2-Expressing Tumors with a Site-Specifically <sup>99m</sup>Tc-Labeled Recombinant Affibody Molecule, Z<sub>HER2:2395</sub>, with C-Terminally Engineered Cysteine.
- Published in:
- Journal of Nuclear Medicine, 2009, v. 50, n. 5, p. 781, doi. 10.2967/jnumed.108.056929
- By:
- Publication type:
- Article
Radiation Dosimetry of β-Amyloid Tracers <sup>11</sup>C-PiB and <sup>18</sup>F-BAY94-9172.
- Published in:
- Journal of Nuclear Medicine, 2009, v. 50, n. 2, p. 309, doi. 10.2967/jnumed.108.055756
- By:
- Publication type:
- Article
Small-Animal PET of Tumor Angiogenesis Using a <sup>76</sup>Br-Labeled Human Recombinant Antibody Fragment to the ED-B Domain of Fibronectin.
- Published in:
- Journal of Nuclear Medicine, 2007, v. 48, n. 7, p. 1172, doi. 10.2967/jnumed.107.040477
- By:
- Publication type:
- Article
Imaging of Tumor Angiogenesis Using <sup>99</sup>mTc-Labeled Human Recombinant Anti-ED-B Fibronectin Antibody Fragments.
- Published in:
- Journal of Nuclear Medicine, 2006, v. 47, n. 10, p. 1707
- By:
- Publication type:
- Article
Radioimmunotherapy of Head and Neck Cancer Xenografts Using <sup>131</sup>I-Labeled Antibody L19-SIP for Selective Targeting of Tumor Vasculature.
- Published in:
- Journal of Nuclear Medicine, 2006, v. 47, n. 7, p. 1127
- By:
- Publication type:
- Article
Targeting of Endothelin Receptors for Molecular Imaging of Atherosclerosis in Rabbits.
- Published in:
- Journal of Nuclear Medicine, 2002, v. 43, n. 3, p. 400
- By:
- Publication type:
- Article
Molecular Imaging of Atherosclerosis Using a Technetium- 99m-Labeled Endothelin Derivative.
- Published in:
- Journal of Nuclear Medicine, 1998, v. 39, n. 10, p. 1819
- By:
- Publication type:
- Article
Comparison of <sup>18</sup>F‐florbetaben quantification results using the standard Centiloid, MR‐based, and MR‐less CapAIBL<sup>®</sup> approaches: Validation against histopathology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, n. 6, p. 807, doi. 10.1016/j.jalz.2019.02.005
- By:
- Publication type:
- Article
IC‐P‐220: CLINICAL UPDATE: <sup>18</sup>F‐PI‐2620, A NEXT GENERATION TAU PET AGENT EVALUATED IN SUBJECTS WITH ALZHEIMER'S DISEASE AND PROGRESSIVE SUPRANUCLEAR PALSY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P179, doi. 10.1016/j.jalz.2018.06.2287
- By:
- Publication type:
- Article
PRECLINICAL CHARACTERIZATION OF PI-2620, A NOVEL TAU PET TRACER FOR DETECTION OF TAU IN AD AND OTHER TAUOPATHIES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P141, doi. 10.1016/j.jalz.2017.06.2567
- By:
- Publication type:
- Article
PRECLINICAL CHARACTERIZATION OF PI-2620, A NOVEL TAU PET TRACER FOR DETECTION OF TAU IN AD AND OTHER TAUOPATHIES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P774, doi. 10.1016/j.jalz.2017.06.1036
- By:
- Publication type:
- Article
FIRST-IN-HUMAN PET STUDIES WITH THE NEXT GENERATION TAU AGENT 18-F PI-2620 IN ALZHEIMER’S DISEASE, PROGRESSIVE SUPRANUCLEAR PALSY, AND CONTROLS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P3, doi. 10.1016/j.jalz.2017.06.2625
- By:
- Publication type:
- Article
Detection of prodromal alzheimer's disease with 18f-florbetaben ab imaging: a prospective outcome study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2014, v. 10, p. P211, doi. 10.1016/j.jalz.2014.04.280
- By:
- Publication type:
- Article
18F-Florbetaben-pet imaging in the differential diagnosis of dementia
- Published in:
- 2010
- By:
- Publication type:
- Abstract
O1-02-07: In vivo characterization of 18F-BAY94-9172: A novel β-amyloid PET ligand for the diagnosis of Alzheimer's disease
- Published in:
- 2008
- By:
- Publication type:
- Abstract
IC-P3-208: In vivo characterization of 18F-BAY94-9172: A novel β-amyloid PET ligand for the diagnosis of Alzheimer's disease
- Published in:
- 2008
- By:
- Publication type:
- Abstract
O1-04-02: Initial results from human studies of a novel F-18 PET ligand for brain beta-amyloid imaging
- Published in:
- 2007
- By:
- Publication type:
- Abstract
Evaluation of dosimetry, quantitative methods and test-retest variability of <sup>18</sup>F-PI-2620 PET for the assessment of tau deposits in the human brain.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.236240
- By:
- Publication type:
- Article
Tau PET imaging with <sup>18</sup>F-PI-2620 in patients with Alzheimer’s disease and healthy controls: a first-in-human study.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.236224
- By:
- Publication type:
- Article
<sup>18</sup>F-GP1, a Novel PET Tracer Designed for High-Sensitivity, Low-Background Detection of Thrombi.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 7, p. 1094, doi. 10.2967/jnumed.116.188896
- By:
- Publication type:
- Article
Exploratory Clinical Investigation of (4S)-4-(3-<sup>18</sup>FFluoropropyl)-L-Glutamate PET of Inflammatory and Infectious Lesions.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 1, p. 67, doi. 10.2967/jnumed.115.164020
- By:
- Publication type:
- Article
Dosimetry and First Clinical Evaluation of the New <sup>18</sup>F-Radiolabeled Bombesin Analogue BAY 864367 in Patients with Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 3, p. 372, doi. 10.2967/jnumed.114.147116
- By:
- Publication type:
- Article
First Clinical Results of (D)-<sup>18</sup>F-Fluoromethyltyrosine (BAY 86-9596) PET/CT in Patients with Non-Small Cell Lung Cancer and Head and Neck Squamous Cell Carcinoma.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 11, p. 1778, doi. 10.2967/jnumed.114.140699
- By:
- Publication type:
- Article
(S)-4-(3-<sup>18</sup>F-Fluoropropyl)-L-Glutamic Acid: An <sup>18</sup>F-Labeled Tumor-Specific Probe for PET/CT Imaging--Dosimetry.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 6, p. 861, doi. 10.2967/jnumed.112.112581
- By:
- Publication type:
- Article
(4S)-4-(3-<sup>18</sup>F-Fluoropropyl)-L-Glutamate for Imaging of x<sub>C</sub> Transporter Activity in Hepatocellular Carcinoma Using PET: Preclinical and Exploratory Clinical Studies.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 1, p. 117, doi. 10.2967/jnumed.112.108704
- By:
- Publication type:
- Article
Preclinical Characterization of a Novel Class of <sup>18</sup>F-Labeled PET Tracers for Amyloid-β.
- Published in:
- Journal of Nuclear Medicine, 2012, v. 53, n. 11, p. 1794, doi. 10.2967/jnumed.112.104810
- By:
- Publication type:
- Article
GLUT 5 Is Not Over-Expressed in Breast Cancer Cells and Patient Breast Cancer Tissues.
- Published in:
- PLoS ONE, 2011, v. 6, n. 11, p. 1, doi. 10.1371/journal.pone.0026902
- By:
- Publication type:
- Article
[<sup>18</sup>F]Fluoropyruvate: radiosynthesis and initial biological evaluation.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2014, v. 57, n. 3, p. 164, doi. 10.1002/jlcr.3183
- By:
- Publication type:
- Article
Commentary to <sup>18</sup>F-GP1, a Novel PET Tracer Designed for High-Sensitivity, Low-Background Detection of Thrombi: Imaging Activated Platelets in Clots—Are We Getting There?
- Published in:
- Molecular Imaging, 2018, v. 17, p. 1, doi. 10.1177/1536012117749052
- By:
- Publication type:
- Article
Discovery and preclinical characterization of [<sup>18</sup>F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 10, p. 2178, doi. 10.1007/s00259-019-04397-2
- By:
- Publication type:
- Article
<sup>18</sup>F-Florbetaben PET beta-amyloid binding expressed in Centiloids.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 12, p. 2053, doi. 10.1007/s00259-017-3749-6
- By:
- Publication type:
- Article
Ethnic comparison of pharmacokinetics of F-florbetaben, a PET tracer for beta-amyloid imaging, in healthy Caucasian and Japanese subjects.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2015, v. 42, n. 1, p. 89, doi. 10.1007/s00259-014-2890-8
- By:
- Publication type:
- Article
Preclinical evaluation of BAY 1075553, a novel <sup>18</sup>F-labelled inhibitor of prostate-specific membrane antigen for PET imaging of prostate cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2014, v. 41, n. 1, p. 89, doi. 10.1007/s00259-013-2527-3
- By:
- Publication type:
- Article
Biodistribution and radiation dosimetry in healthy volunteers of a novel tumour-specific probe for PET/CT imaging: BAY 85-8050.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2013, v. 40, n. 12, p. 1861, doi. 10.1007/s00259-013-2502-z
- By:
- Publication type:
- Article
<sup>124</sup>I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of <sup>131</sup>I-L19-SIP radioimmunotherapy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2009, v. 36, n. 8, p. 1235, doi. 10.1007/s00259-009-1096-y
- By:
- Publication type:
- Article
Molecular targeting of angiogenesis for imaging and therapy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2004, v. 31, n. 9, p. 1327, doi. 10.1007/s00259-004-1648-0
- By:
- Publication type:
- Article
Application of locked nucleic acids to improve aptamer in vivo stability and targeting function.
- Published in:
- Nucleic Acids Research, 2004, v. 32, n. 19, p. 5757, doi. 10.1093/nar/gkh862
- By:
- Publication type:
- Article
Molecular imaging in drug development.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 7, p. 591, doi. 10.1038/nrd2290
- By:
- Publication type:
- Article
Comparison of [(11)C]Choline ([(11)C]CHO) and [(18)F]Bombesin (BAY 86-4367) as Imaging Probes for Prostate Cancer in a PC-3 Prostate Cancer Xenograft Model.
- Published in:
- 2016
- By:
- Publication type:
- journal article
BAY 1075553 PET-CT for Staging and Restaging Prostate Cancer Patients: Comparison with [18F] Fluorocholine PET-CT (Phase I Study).
- Published in:
- 2015
- By:
- Publication type:
- journal article
BAY 1075553 PET-CT for Staging and Restaging Prostate Cancer Patients: Comparison with [F] Fluorocholine PET-CT (Phase I Study).
- Published in:
- Molecular Imaging & Biology, 2015, v. 17, n. 3, p. 424, doi. 10.1007/s11307-014-0800-x
- By:
- Publication type:
- Article
Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies.
- Published in:
- PLoS ONE, 2016, v. 11, n. 2, p. 1, doi. 10.1371/journal.pone.0148628
- By:
- Publication type:
- Article